Forskolin, is a well-known activator of adenylyl cyclase, thereby ramping up the levels of cyclic AMP, a pivotal second messenger within the cell. This elevation in cAMP can lead to the activation of various proteins downstream of G-protein-coupled receptors, which could include RGP1 if it were responsive to such signals. Isoproterenol, a synthetic compound, stimulating beta-adrenergic receptors, culminating in an increase in intracellular cAMP. Prostaglandin E2 (PGE2), another endogenous molecule, interacts with its specific GPCR to initiate a distinct signaling route, which could likewise intersect with the regulatory network of RGP1.
The inclusion of Guanosine 5'-O-(3-thiotriphosphate) tetralithium salt, a non-hydrolyzable analogue of GTP, reflects its utility in sustaining the activation of G-proteins, thereby providing a constant stimulatory signal that could propagate through the pathways involving RGP1. IBMX, on the other hand, prevents the breakdown of cAMP by inhibiting phosphodiesterases, thereby maintaining an elevated signal within the cell that could indirectly promote RGP1 activity. Histamine, Acetylcholine, and Angiotensin II target their respective receptors, each setting in motion a unique signaling pathway. These endogenous compounds illustrate the intricate web of cellular communication, where the activation or inhibition of one receptor type can have wide-reaching implications, potentially influencing the function of a myriad of proteins including RGP1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly activates adenylyl cyclase, increasing intracellular cAMP levels, which can enhance the activity of proteins downstream of GPCRs. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
A synthetic agonist for beta-adrenergic receptors, can increase cAMP in cells, which may indirectly activate RGP1 if it is cAMP-responsive. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $56.00 $156.00 $270.00 $665.00 | 37 | |
Prostaglandin E2 activates its GPCR, which could lead to downstream signaling events that activate RGP1. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $456.00 | ||
A non-hydrolyzable GTP analog that can activate G-proteins and potentially enhance RGP1 activity if it interacts with G-protein signaling. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Inhibits phosphodiesterases, leading to increased cAMP levels, which could indirectly increase RGP1 activity. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $92.00 $277.00 $969.00 | 7 | |
Activates histamine receptors, which can trigger signaling pathways that may involve RGP1. | ||||||
Angiotensin II, Human | 4474-91-3 | sc-363643 sc-363643A sc-363643B sc-363643C | 1 mg 5 mg 25 mg 100 mg | $50.00 $75.00 $260.00 $505.00 | 3 | |
Activates angiotensin receptors, which might lead to activation of proteins in the RGP1-related pathways. | ||||||